FoxM1: A potential drug target for glioma

Future Oncology

Volumn 8, Issue 3, 2012, Pages 223-226

  Li, Yu ^a   Zhang, Sicong ^a   Huang, Suyun ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

angiogenesis; drug target; FoxM1; glioma; invasion; proliferation; self renewal

Indexed keywords

BEVACIZUMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; EVEROLIMUS; FORKHEAD TRANSCRIPTION FACTOR; RAPAMYCIN; RIDAFOROLIMUS; TEMSIROLIMUS; TRANSCRIPTION FACTOR FOXM1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; CANCER GROWTH; CANCER STEM CELL; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL INVASION; CELL PROLIFERATION; CELL RENEWAL; DRUG TARGETING; EXON; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC HETEROGENEITY; GLIOBLASTOMA; GLIOMA CELL; HUMAN; MITOSIS; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; RNA SPLICING; SIGNAL TRANSDUCTION; UPREGULATION;

CYCLIN-DEPENDENT KINASE INHIBITOR P16; DRUG DELIVERY SYSTEMS; FORKHEAD TRANSCRIPTION FACTORS; GLIOMA; HUMANS; MOLECULAR TARGETED THERAPY; PEPTIDES; RNA, MESSENGER;

EID: 84863344471     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.12.1     Document Type: Review

References (20)

1. Friedman HS, Prados MD, Wen PY et al. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J. Clin. Oncol. 27(28), 4733-4740 (2009
2. Sathornsumetee S, Reardon DA, Desjardins A, Quinn JA, Vredenburgh JJ, Rich JN. Molecularly targeted therapy for malignant glioma. Cancer 110(1), 13-24 (2007
3. Koo CY, Muir KW, Lam EW. FOXM1: From cancer initiation to progression and treatment. Biochim. Biophys. Acta 1819(1), 28-37 (2011
4. Wang IC, Chen YJ, Hughes D et al. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol. Cell. Biol. 25(24), 10875-10894 (2005
5. Laoukili J, Kooistra MR, Bras A et al. FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat. Cell Biol. 7(2), 126-136 (2005
6. Myatt SS, Lam EW. The emerging roles of forkhead box (Fox) proteins in cancer. Nat. Rev. Cancer 7(11), 847-859 (2007
7. Wang Z, Ahmad A, Li Y, Banerjee S, Kong D, Sarkar FH. Forkhead box M1 transcription factor: A novel target for cancer therapy. Cancer Treat. Rev. 36(2), 151-156 (2010
8. Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 474(7353), 609-615 (2011
9. Liu M, Dai B, Kang SH et al. FoxM1b is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. Cancer Res. 66(7), 3593-3602 (2006
10. Zhang Y, Zhang N, Dai B et al. FoxM1b transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells. Cancer Res. 68(21), 8733-8742 (2008
11. Dai B, Kang SH, Gong W et al. Aberrant FoxM1b expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells. Oncogene 26(42), 6212-6219 (2007
12. Zhang N, Wei P, Gong A et al. FoxM1 promotes beta-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis. Cancer Cell 20(4), 427-442 (2011
13. Kalinichenko VV, Major ML, Wang X et al. FoxM1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev. 18(7), 830-850 (2004
14. Radhakrishnan SK, Bhat UG, Hughes DE, Wang IC, Costa RH, Gartel AL. Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1. Cancer Res. 66(19), 9731-9735 (2006
15. Halasi M, Zhao H, Dahari H et al. Thiazole antibiotics against breast cancer. Cell Cycle 9(6), 1214-1217 (2010
16. Priller M, Pöschl J, Abrão L et al. Expression of FoxM1 is required for the proliferation of medulloblastoma cells and indicates worse survival of patients. Clin. Cancer Res. 17(21), 6791-6801 (2011
17. Nakano I, Joshi K, Visnyei K et al. Siomycin A targets brain tumor stem cells partially through a MELK-mediated pathway. Neuro Oncol. 13(6), 622-634 (2011
18. Nicolaou KC, Zak M, Rahimipour S et al. Discovery of a biologically active thiostrepton fragment. J. Am. Chem. Soc. 127(43), 15042-15044 (2005
19. Kwok JM, Myatt SS, Marson CM, Coombes RC, Constantinidou D, Lam EW. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression. Mol. Cancer Ther. 7(7), 2022-2032 (2008
20. Hegde NS, Sanders DA, Rodriguez R, Balasubramanian S. The transcription factor FOXM1 is a cellular target of the natural product thiostrepton. Nat. Chem. 3(9), 725-731 (2011)